Literature DB >> 25033267

Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.

Thomas Günther1, Sabrina Schreiner2, Thomas Dobner2, Uwe Tessmer1, Adam Grundhoff1.   

Abstract

We have previously demonstrated that acquisition of intricate patterns of activating (H3K4me3, H3K9/K14ac) and repressive (H3K27me3) histone modifications is a hallmark of KSHV latency establishment. The precise molecular mechanisms that shape the latent histone modification landscape, however, remain unknown. Promyelocytic leukemia nuclear bodies (PML-NB), also called nuclear domain 10 (ND10), have emerged as mediators of innate immune responses that can limit viral gene expression via chromatin based mechanisms. Consequently, although ND10 functions thus far have been almost exclusively investigated in models of productive herpesvirus infection, it has been proposed that they also may contribute to the establishment of viral latency. Here, we report the first systematic study of the role of ND10 during KSHV latency establishment, and link alterations in the subcellular distribution of ND10 components to a temporal analysis of histone modification acquisition and host cell gene expression during the early infection phase. Our study demonstrates that KSHV infection results in a transient interferon response that leads to induction of the ND10 components PML and Sp100, but that repression by ND10 bodies is unlikely to contribute to KSHV latency establishment. Instead, we uncover an unexpected role for soluble Sp100 protein, which is efficiently and permanently relocalized from nucleoplasmic and chromatin-associated fractions into the insoluble matrix. We show that LANA expression is sufficient to induce Sp100 relocalization, likely via mediating SUMOylation of Sp100. Furthermore, we demonstrate that depletion of soluble Sp100 occurs precisely when repressive H3K27me3 marks first accumulate on viral genomes, and that knock-down of Sp100 (but not PML or Daxx) facilitates H3K27me3 acquisition. Collectively, our data support a model in which non-ND10 resident Sp100 acts as a negative regulator of polycomb repressive complex-2 (PRC2) recruitment, and suggest that KSHV may actively escape ND10 silencing mechanisms to promote establishment of latent chromatin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25033267      PMCID: PMC4102598          DOI: 10.1371/journal.ppat.1004274

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  142 in total

Review 1.  PML nuclear bodies: dynamic sensors of DNA damage and cellular stress.

Authors:  Graham Dellaire; David P Bazett-Jones
Journal:  Bioessays       Date:  2004-09       Impact factor: 4.345

2.  SP100B, a repressor of gene expression preferentially binds to DNA with unmethylated CpGs.

Authors:  Anne Isaac; Kent W Wilcox; Jerry L Taylor
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

3.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Authors:  M E Ballestas; P A Chatis; K M Kaye
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

4.  Three-dimensional organization of promyelocytic leukemia nuclear bodies.

Authors:  Marion Lang; Thibaud Jegou; Inn Chung; Karsten Richter; Sandra Münch; Anikó Udvarhelyi; Christoph Cremer; Peter Hemmerich; Johann Engelhardt; Stefan W Hell; Karsten Rippe
Journal:  J Cell Sci       Date:  2010-02-01       Impact factor: 5.285

5.  The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.

Authors:  Thomas Günther; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

6.  Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.

Authors:  Jin He; Li Shen; Ma Wan; Olena Taranova; Hao Wu; Yi Zhang
Journal:  Nat Cell Biol       Date:  2013-03-17       Impact factor: 28.824

7.  Architectural and functional diversity of polycomb group response elements in Drosophila.

Authors:  J Lesley Brown; Judith A Kassis
Journal:  Genetics       Date:  2013-08-09       Impact factor: 4.562

8.  Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.

Authors:  Eriko Ohsaki; Tohru Suzuki; Masato Karayama; Keiji Ueda
Journal:  Virus Res       Date:  2008-12-09       Impact factor: 3.303

9.  Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.

Authors:  Nina Tavalai; Thomas Stamminger
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

Review 10.  PML and PML nuclear bodies: implications in antiviral defence.

Authors:  Roger D Everett; Mounira K Chelbi-Alix
Journal:  Biochimie       Date:  2007-01-27       Impact factor: 4.079

View more
  35 in total

Review 1.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.

Authors:  Magdalena Weidner-Glunde; Giuseppe Mariggiò; Thomas F Schulz
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

2.  Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.

Authors:  J Berscheminski; J Brun; T Speiseder; P Wimmer; W H Ip; M Terzic; T Dobner; S Schreiner
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

Review 3.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

4.  A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.

Authors:  Crystal Woodard; Gangling Liao; C Rory Goodwin; Jianfei Hu; Zhi Xie; Thaila F Dos Reis; Rob Newman; Heesool Rho; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

5.  Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.

Authors:  Pravinkumar Purushothaman; Suhani Thakker; Subhash C Verma
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

Review 6.  Viral gene products actively promote latent infection by epigenetic silencing mechanisms.

Authors:  David M Knipe; Priya Raja; Jennifer Lee
Journal:  Curr Opin Virol       Date:  2017-04-14       Impact factor: 7.090

Review 7.  The Restrictome of Flaviviruses.

Authors:  Lionel Berthoux
Journal:  Virol Sin       Date:  2020-03-09       Impact factor: 4.327

8.  Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.

Authors:  Zsolt Toth; Richard J Smindak; Bernadett Papp
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

9.  KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification.

Authors:  Carolin Bürck; Andreas Mund; Julia Berscheminski; Lisa Kieweg; Sarah Müncheberg; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

Review 10.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.